Arcadia Biosciences (RKDA) Tops Q2 EPS by 2c, Miss on Revenues

Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $991 thousand versus the consensus estimate of $1.3 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge
• Robinhood prices $2B convertible notes offering due 2029